Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

March 21, 2016

New York/Geneva, March 21, 2016—Two years after two new drugs to treat tuberculosis (TB)—the first in over 50 years—were conditionally approved for use, only two percent of the 150,000 people who need them most have been able to access them, according to Doctors Without Borders’ new edition of DR-TB Drugs Under the Microscope.

November 30, 2015

JOHANNESBURG/HARARE—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today warned that lifesaving antiretroviral medicines (ARVs) are routinely not making their way to patients in sub-Saharan Africa, most often despite sufficient stocks already being present in countries, and called for urgent improvements in ARV supply chains in the region.

October 28, 2015

JOHANNESBURG—After six months of persistent supply problems with the key HIV medicine lopinavir/ritonavir (LPV/r), the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) urged the South African government to put the public’s health first and override pharmaceutical company AbbVie’s patent with a "compulsory licence," in order to allow generic versions of LPV/r to be used in the country.

March 19, 2015

Doctors Without Borders and research center in Borstel, Germany, publish findings in New England Journal of Medicine.

March 06, 2014

Boston/New York, March 6, 2014—Two new studies released today by Epicentre,the research arm of the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at CROI, the Conference on Retroviruses and Opportunistic Infections, point to reductions in new HIV infections in areas where HIV treatment has been greatly expanded. The studies are some of the first to look at large-scale antiretroviral therapy (ART) rollout in real-world high-HIV-burden settings in sub-Saharan Africa, and its possible impact on reducing new infections.

January 21, 2014

JOHANNESBURG/NEWYORK, JANUARY 21, 2014—The international medical humanitarian organization Doctor Without Borders/Médecins Sans Frontières (MSF) is urging the South African government to continue to stand strong against a broad, multinational pharmaceutical industry effort to undermine and delay the efforts to reform patent laws and improve access to affordable medicines.

January 21, 2014

JOHANNESBURG/NEWYORK, JANUARY 21, 2014—The international medical humanitarian organization Doctor Without Borders/Médecins Sans Frontières (MSF) is urging the South African government to continue to stand strong against a broad, multinational pharmaceutical industry effort to undermine and delay the efforts to reform patent laws and improve access to affordable medicines.

December 07, 2011

MSF study shows cryptococcal meningitis as leading cause of death, but access to best treatment is a major challenge

November 21, 2011

Without appropriate funding, the opportunity to reap the benefits of new science showing that HIV treatment both saves lives and helps prevent new infections could be lost.

September 12, 2011

As the Measles Initiative meets in Washington, D.C., MSF is calling for an effective outbreak response mechanism to be established immediately to deal with the rising numbers of severe outbreaks worldwide. 

Pages